Petros Pharmaceuticals, Inc. engages in identifying, acquiring, developing, and commercializing therapeutics for men's health issues. The company operates through two segments, Prescription Medications and Medical Devices. It focuses on erectile dysfunction, peyronie's disease, endothelial dysfunction, and prostate cancer; and hormone health, and products enhancing overall health and wellness in men. The company offers prescription medication, such as Stendra for the treatment of erectile dysfunction; and vacuum erection devices. Petros Pharmaceuticals, Inc. is based in New York, New York.